Longitudinal Change in CSF Biomarkers in Autosomal-Dominant Alzheimer’s Disease

2014 Science Translational Medicine 422 citations

Abstract

Longitudinal cerebrospinal fluid biomarker analyses reveal decreases in neuronal injury markers in later stages of autosomal-dominant Alzheimer’s disease.

Keywords

BiomarkerAsymptomaticMedicineDiseaseCerebrospinal fluidAlzheimer's diseasePathologyOncologyCognitive declineAmyloid (mycology)Internal medicineDementiaBiologyGenetics

Affiliated Institutions

Related Publications

The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

The National Institute on Aging and the Alzheimer's Association charged a workgroup with the task of developing criteria for the symptomatic predementia phase of Alzheimer's dis...

2011 Alzheimer s & Dementia 9670 citations

Publication Info

Year
2014
Type
article
Volume
6
Issue
226
Pages
226ra30-226ra30
Citations
422
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

422
OpenAlex

Cite This

Anne M. Fagan, Chengjie Xiong, Mateusz S. Jasielec et al. (2014). Longitudinal Change in CSF Biomarkers in Autosomal-Dominant Alzheimer’s Disease. Science Translational Medicine , 6 (226) , 226ra30-226ra30. https://doi.org/10.1126/scitranslmed.3007901

Identifiers

DOI
10.1126/scitranslmed.3007901